Our vital role in the U.S. pharmaceutical supply chain
Our $1 billion investment in the U.S. supply chain through 2030 enhances the capacity, efficiency, and resilience of the national prescription drug distribution network. We continue to expand advanced capabilities for controlled, refrigerated, frozen, ultra-low, and cryogenic storage to support the growing demand for the newest and most innovative specialty therapies, such as cell and gene, that can treat rare diseases.
Accelerating positive patient outcomes with innovative solutions
Cencora combines expertise in pharmaceutical distribution and operations with a deep understanding of market access dynamics. We deliver effective solutions that help advance pharmaceutical innovation for our manufacturer partners and patient access to all types of pharmaceutical care sites, ranging from health systems to community-based specialty practices and independent pharmacies.
Our solutions span the healthcare spectrum, including:
- Wholesale and specialty distribution
- Commercialization support
- Specialty logistics and warehousing
- Packaging solutions
- Data management
- Patient access and adherence support
- Pharmacy solutions
- Provider solutions, including support for independent providers to reduce administrative burden so they can focus on patients
Who we serve
Advocating together for affordable, accessible pharmaceutical care
Our purpose to create healthier futures aligns to our public policy priorities, which include:
- Safeguarding public health and safety by upholding the integrity of one of the world’s most secure pharmaceutical supply chains
- Mitigating drug shortages
- Expanding access by reimbursing providers adequately and fairly for patient care and services
- Ensuring patient access to the right therapy at the most accessible and affordable sites of care.
When we work together, we can make a greater impact on health.
For example, drug shortages, particularly of generic drugs, negatively impact millions of patients and healthcare providers across the U.S. These shortages are complex and require coordinated public-private efforts to identify contributing factors and develop effective policy solutions. As a vital member of the pharmaceutical supply chain, Cencora aims to collaborate with federal and state policymakers to enhance care delivery, improve reimbursement processes, and increase supply chain transparency and resilience.
Download this white paper to learn about our recommended approaches to combat generic drug shortages and improve patient access, while improving U.S. national security.
